AXA (CS) Given a €26.00 Price Target by UBS Group Analysts
AXA (EPA:CS) has been given a €26.00 ($30.95) target price by equities researchers at UBS Group in a report issued on Tuesday, www.boersen-zeitung.de reports. The brokerage currently has a “neutral” rating on the stock. UBS Group’s target price would suggest a potential downside of 3.27% from the company’s current price.
Several other equities research analysts also recently issued reports on the company. Deutsche Bank set a €28.50 ($33.93) price target on AXA and gave the company a “buy” rating in a research report on Wednesday, November 22nd. Kepler Capital Markets set a €29.80 ($35.48) price target on AXA and gave the company a “buy” rating in a research report on Friday, November 3rd. Goldman Sachs Group set a €24.80 ($29.52) price target on AXA and gave the company a “neutral” rating in a research report on Monday, December 11th. Bank of America set a €29.00 ($34.52) price target on AXA and gave the company a “buy” rating in a research report on Wednesday, December 13th. Finally, JPMorgan Chase & Co. set a €28.80 ($34.29) price target on AXA and gave the company a “buy” rating in a research report on Thursday, October 12th. Five equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of €27.83 ($33.13).
Shares of AXA (CS) opened at €26.88 ($32.00) on Tuesday. The stock has a market capitalization of $65,190.00 and a PE ratio of 11.44. AXA has a 1 year low of €21.81 ($25.96) and a 1 year high of €27.04 ($32.19).
AXA SA (AXA) is a France-based holding company engaged in the business of financial protection. The Company’s segments include Life & Savings, Property & Casualty, Asset Management , Banking and Holding companies. The Life & Savings segment’s products include a range of investment and savings products, as well as Protection and Health products.
Receive News & Ratings for AXA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AXA and related companies with MarketBeat.com's FREE daily email newsletter.